Impact of patient outcomes and cost aspects on reimbursement recommendations in Poland

The journal Health policy has published a study regarding the impact of patient outcomes and cost aspects on reimbursement recommendations in Poland in 2012-2014. They have analysed all recommendations for the period of 2012-2014 in Poland, three years following the launch of the new Reimbursement Act of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices. For each recommendation they have collected data on efficacy, safety, cost of therapy, cost-effectiveness, quality of evidence, orphan drug status and others. Logistic regression was used to identify factors that increase the odds of a positive reimbursement recommendation. Were analysed 221 recommendations for drugs, of which 78% were positive. The full-text study you can find here.